Christian Behrenbruch

Christian Behrenbruch

Company: Telix Pharmaceuticals

Job title: Managing Director & Chief Executive Officer


Radioactive ADCs in Oncology & Autoimmune Diseases 2:30 pm

• Radioimmunoconjugates are not a new class of drugs but improvements in conjugation technology, choices of isotopes and antibody engineering techniques has generated new interest • Highlighting significant opportunities in both diagnostic and therapeutic medicine • Outlining a number of recent late-stage developments in this exciting field, as well as potentially important new platform technologies…Read more

day: day 2 opps
day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.